Table 1.

Descriptive characteristics of patients.

	Placebo (n=29)	Chamomile (n=28)	P
Gender (F/M)	15:14	19:09	0.21
Caucasian (%)	68.97	78.57	0.41
Age (mean ± SD)	45.9 (10.88)/33–69	45.5 (14.53)/25–67	0.98
Age at onset GAD (mean ± SD)/range	25.3 (13.5)/7–75	27.9 (11.3)/14–58	0.25
Illness duration (mean ± SD)/range (yrs)	20.4(13.4)/0.3–54	15.0 (14.4)/1–51	0.11
Episode duration (mean ± SD)/range (mos)	42.9 (58.6)/2–240	54.3 (64.0)/6–256	0.22
# prior episodes (mean ± SD)/range	3.6 (5.7)/0–30	4.7 (9.1)/0–43	0.74
Baseline HAM-A (mean ± SD)/range	14.3 (2.8)/10–20	15.4 (4.2)/9–26	0.39
Baseline BAI (mean ± SD)/range	12.0 (6.2)/3–23	9.5 (5.6)/2–21	0.13
Baseline PGWB (mean ± SD)/range	58.9 (14.1)/31–91	62.0 (14.7)/23–86	0.31